Literature DB >> 10141946

The Patient Self-Determination Act. A matter of life and death.

K Kelley1.   

Abstract

The Patient Self-Determination Act (PSDA) is a federal law, and compliance is mandatory. It is the purpose of this act to ensure that a patient's right to self-determination in health care decisions be communicated and protected. Through advance directives--the living will and the durable power of attorney--the right to accept or reject medical or surgical treatment is available to adults while competent, so that in the event that such adults become incompetent to make decisions, they would more easily continue to control decisions affecting their health care. Without advance directives and the proper adherence to such directives, former President Richard Nixon and former First Lady Jacqueline Kennedy Onassis might still be alive today, in persistent vegetative states. This article examines the history of the act, its importance to each individual, the clinical, ethical and legal issues, and the role of health care professionals in effectively implementing and ensuring compliance of the PSDA.

Entities:  

Keywords:  Cruzan v. Harmon; Death and Euthanasia; Legal Approach

Mesh:

Year:  1995        PMID: 10141946

Source DB:  PubMed          Journal:  Physician Assist        ISSN: 1538-8697


  3 in total

Review 1.  Aligning use of intensive care with patient values in the USA: past, present, and future.

Authors:  Alison E Turnbull; Gabriel T Bosslet; Erin K Kross
Journal:  Lancet Respir Med       Date:  2019-05-20       Impact factor: 30.700

2.  What Patients, Families, Health Professionals and Hospital Volunteers Told Us about Advance Directives.

Authors:  Carmen W H Chan; Martin M H Wong; Kai Chow Choi; Helen Y L Chan; Amy Y M Chow; Raymond S K Lo; Michael M K Sham
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jan-Mar

3.  Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea.

Authors:  Dalyong Kim; Shin Hye Yoo; Seyoung Seo; Hyun Jung Lee; Min Sun Kim; Sung Joon Shin; Chi-Yeon Lim; Do Yeun Kim; Dae Seog Heo; Chae-Man Lim
Journal:  Cancer Res Treat       Date:  2021-04-12       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.